M. Hirasa et al. / Journal of Organometallic Chemistry 692 (2007) 93–110
95
Table 1
1H NMR data for pH-indicator complexesa,b
Compound (solvent)
Cp*
Coordinated Ar
Non-coordinated Ar
NMe2
3.13
5a Æ PF6 (CD2Cl2)
5b Æ PF6 (CD2Cl2)
5a0 Æ PF6 (CD2Cl2)
1.88
1.94
1.90
6.40 (2H, d, 6.2), 5.97 (2H, m), 5.85 (1H, m)
6.23 (2H, d, 7.6), 5.51 (2H, d, 7.6)
6.41 (1H, d, 6.4), 6.10 (2H, m), 6.04 (1H, d, 5.1)
7.86 (2H, d, 7.2), 6.76 (2H, d, 7.2)
7.7 (2H, m), 7.4 (3H, m)
7.76 (2H, d, 9.2), 7.38 (4H, m), 7.17–7.24
(6H, m), 7.03 (2H, d, 9.2)
6a (acetone-d6)
6b (acetone-d6)
7 Æ PF6 (CD3CN)
6.29 (2H, d, 6.8), 5.86 (2H, m), 5.70 (1H, m)
6.64 (2H, d, 7.6), 5.59 (2H, d, 7.6)
5.95 (2H, d, 6.7), 5.91 (2H, d, 6.7), 5.31
(2H, d, 6.7), 5.25 (2H, d, 6.7)
5.86 (2H, d. 6.8), 5.77 (2H, d, 6.8), 5.25
(2H, d, 6.8), 5.18 (2H, d, 6.8)
7.79 (2H, d, 9.4), 6.84 (2H, d, 9.4)
7.82 (2H, m,), 7.55 (3H, m)
7.59 (1H, d, 8.4), 7.17 (1H, d, 8.6), 7.12
(1H, s), 6.86 (2H, d, 9.0), 6.61 (2H, d, 9.0)
7.78 (1H, d, 9.6), 7.25–7.29 (2H, m)
3.13
3.06
3.03, 3.01, 2.87
–
1.65
8 Æ (PF6)2 (CD3CN)
10 (C6D6)
1.63
–
3.07, 2.98
5.66–5.62 (2H, m), 4.18 (1H, d, 5.7)
7.95 (2H, d, 8.8), 7.42 (2H, d, 8.8),
6.60 (2H, d, 9.0), 6.42 (2H, d, 9.0)
7.21–7.03 (8H, m)
2.51, 2.45, 2.23
12 (DMSO-d6)
13a (CDCl3)
–
–
5.36 (1H, s), 5.28 (1H, d, 6.8), 4.97 (1H, d, 6.8)
6.14 (1H, d, 6.1), 5.00 (1H, s), 4.67 (1H, d, 5.6)
ꢀ3.10 (br.)
7.70 (2H, d, 8.6), 6.99 (2H, d, 8.6),
6.71 (2H, d, 8.6), 6.55 (2H, d, 8.6)
7.67 (2H, d, 8.3), 6.96 (2H, d, 8.3),
6.70 (2H, d, 8.5), 6.54 (2H, d, 8.3)
7.12 (2H, d, 8.6), 6.95 (2H, d, 8.6),
6.70 (2H, d, 8.6), 6.64 (2H, d, 8.6)
7.11 (2H, d, 8.4), 6.95 (2H, d, 8.4),
6.65–6.57 (4H, m)
3.30, 3.23, 2.95, 2.91
3.24, 2.93, 2.89
3.10, 3.02, 2.88, 2.86
2.90–2.84
13b (CDCl3)
14a (CD3CN)
14b (CDCl3)
16 (CDCl3)
a
–
6.31 (1H, d, 6.6), 5.30 (1H, d, 6.6), 4.76 (1H, s)
5.51 (1H, d, 6.6), 4.63 (1H, d, 6.1), 4.29 (1H, s)
5.77 (1H, s), 5.27 (1H, m), 3.96 (1H, d, 5.8)
–
–
1.60
5.62 (1H, d, 7.4), 5.43 (1H, d, 7.4), 4.79
(1H, d, 7.4), 4.75 (1H, d, 7.4)
8.00 (1H, d, 7.6), 7.71–7.50 (3H, m),
6.82 (2H, d, 8.6), 6.69 (2H, d, 8.6)
–
dH in ppm. Coupling pattern and coupling constant (in Hz) are shown in parentheses.
For other signals: 10: cod signals: 3.66–3.44 (4H, m), 2.45–2.23 (8H, m). 13a: piperidine: 2.43–1.17. 13b: PEt3: 1.80 (6H, m, CH2), 0.87 (9H, m, CH3).
12: 6.21 (CH). 14a: 7.83 (1H, s, NH), 5.86 (1H, s, CH), 3.18–1.31 (piperidine). 14b: 5.37 (1H, s), 1.32 (6H, CH2), 0.88 (9H, CH3).
b
3). The compositions (1:1 adducts) were readily determined
on the basis of the intensities of the H NMR signals for
can be interpreted as follows. The direct reaction with 1
1
results in coordination to the electron-rich b ring bearing
the NMe2 group. Protonation of 1 occurs at the nitrogen
atom attached to the a ring to decrease the electron density
of the b ring and, therefore, the RuCp*+ fragment should
be attached to the more electron-rich a ring in the proton-
ated form ([1+H]+) to give 5a Æ PF6. Contribution of the
the MY and Cp* ligands (Table 1), and the coordination
sites were also readily determined on the basis of the
assignments of the aromatic signals shifted to higher field
(Fig. 1 and Table 1). It is established that coordination
of an aromatic group to a transition metal species in g6-
fashion causes upfield-shifts of the aromatic proton signals
[4–6]. As shown in Fig. 1, the signals for the a and b rings
are assigned on the basis of the coupling patterns; a ring:
three multiplet signals for the o-, m-, and p-hydrogen
atoms; b ring: a pair of coupled doublets (dH 6.76, 7.91
(d, J = 7.2 Hz)). In the case of 5a Æ PF6, the signals assigned
to the a ring are shifted to higher field leading to the assign-
ment to the a ring adduct. On the other hand, the 1H NMR
spectrum of 5b Æ PF6 contains the doublet pairs shifted to
higher field leading to the assignment to the b ring adduct.
Thus it is revealed that the major product 5b Æ PF6 results
from coordination to the C6H4–NMe2 part (b ring). The
assignments have been verified by X-ray crystallography
(Fig. 2a and b). A remarkable difference is noted for
UV–Vis spectra. The a ring adduct 5a Æ PF6 shows a visible
absorption at 504 nm with the intensity comparable to that
of 1, whereas the intensity of the 500 nm absorption
observed for 5b Æ PF6 is much weaker that those of 5a Æ PF6
and 1 presumably because of the negligible contribution of
the colored, quinoidal form (see F0 in Scheme 9).
+
quinoidal form ([1+H]0 in Scheme 2), which cannot be
coordinated in a g6-fashion, should also promote coordi-
nation to the aromatic a ring.
For comparison sake, the NPh2 derivative of 5 Æ PF6
(5a0 Æ PF6) was also prepared. In this case, the adduct of
the a ring (5a0 Æ PF6) was obtained as the major product
(5a0 Æ PF6:5b0 Æ PF6 = 5:2) even from the non-protonated
precursor 10, presumably because (i) the lone pair electrons
on the NPh2 part are delocalized over the NAr3 part to
decrease electron density of the a ring (compared to 1)
and (ii) the bulky Ph substituents may hinder approach
of the bulky RuCp* fragment to the b ring. Reaction with
[10-H]OTf improved the selectivity for 5a0 Æ PF6 (5a0 Æ
PF6:5b0 Æ PF6 = 8:1). The adduct of the NPh2 part was
not detected at all.
Preparation of the RuCl2(L) adduct was also attempted
but reaction of 1 with Ru(cod)(naphthalene) did not afford
the desired g6-arene complex, (g6-MY)Ru(cod), as
observed for CVL (see below). Because azobenzene with-
out the NMe2 group gave the 1:1 adduct, (g6-azoben-
1
It is notable that the analogous reaction of the proton-
ated form of 1, [1+H] Æ OTf, inverted the isomer ratio to
give 5a Æ PF6 as the dominant product (5:1). These results
zene)Ru(cod), as judged by H NMR, the failure in the
formation of the 1-adduct should be ascribed to the
NMe2 substituent, which might work as a r-donor.